novo nordisk wegovy - Search News

News

Novo Nordisk, compounded weight loss drugs

Seeking Alpha on MSN · 7h

Novo Nordisk expands legal battle over compounded weight loss drugs

Novo Nordisk (NVO) files additional court cases against vendors selling cheaper semaglutide knockoffs. Read more here.

The Wall Street Journal on MSN · 6d

Novo Nordisk Shares Plummet as Competition Weighs on Sales

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

Reuters on MSN · 6h

Novo Nordisk expands lawsuits against weight-loss drug compounders

By Christy Santhosh (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of unapproved versions of semaglutide, the active ingredient in its popular weight-loss and diabetes drugs,

Novo Nordisk’s Earnings Come

Barron's on MSN · 4h

Novo Nordisk’s Earnings Come After a Dramatic Guidance Cut. What to Look for Now.

The company also announced a new CEO, Maziar Mike Doustdar, a Novo executive who formerly led international operations for the company. Doustdar will succeed Lars Fruergaard Jørg

MarketWatch · 14h

Novo Nordisk to Disclose Full Second-Quarter Earnings Amid Management Reshuffle -- Earnings Preview

Novo Nordisk is scheduled to report results for the second quarter on Wednesday. Here is what you need to know: PROFIT FORECAST: The company pre-released preliminary second-quarter numbers last week,

Barchart on MSN · 10h

Is Novo Nordisk Stock a Buy, Sell, or Hold Before Q2 Earnings?

Danish pharmaceutical giant Novo Nordisk A/S (NVO) is facing serious headwinds. After enjoying a strong run fueled by demand for its obesity treatments, the obesity drug pioneer is now under pressure from rising competition,

1don MSN

Noom launches microdose copies of Novo's Wegovy at $119

Noom introduces affordable options for obesity treatments, including Novo Nordisk's Wegovy and GLP-1Rx programs. Read more ...

9hon MSN

Why Novo Nordisk Stock Is Down Again Today

Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo ...

4don MSN

Novo Nordisk shares dip further as Wegovy gains nearly erased

Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent ...

Stocktwits on MSN12h

Novo Nordisk Downgraded By UBS Over Uncertain Outlook For Wegovy, But Retail Prefers To Look At The Sunny Side

NYSE-listed shares of Danish drugmaker Novo Nordisk (NVO) fell about 3% on Tuesday morning after brokerage UBS downgraded the ...

4don MSN

Why Novo Nordisk Stock Imploded This Week

Shares of Novo Nordisk ( NVO 2.48%) are falling this week, down 33% as of 3:27 p.m. ET on Friday. The drop comes as the S&P ...

1d

Wegovy maker Novo hit with investor class action over revenue forecast cut

Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...

6hOpinion

Your Wegovy May Pay for Itself

The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.

7h

Novo Nordisk Faces Ozempic-Linked Securities Fraud Claims

Levi & Korsinsky is representing the shareholder plaintiff in a suit claiming the Ozempic and Wegovy manufacturer withheld ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results